Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial

Clinical trial NCT03836716 · TERMINATED

Trial details

NCT number: NCT03836716
Sponsor: ZevraDenmark
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2019-09-19
Primary completion: 2021-07-02
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.